Medirom Healthcare Technologies (MRM) Cash & Equivalents (2020 - 2025)

Medirom Healthcare Technologies' Cash & Equivalents history runs 6 years deep, the most recent figure standing at $225737.5 for Q2 2025.

• In Q2 2025, Cash & Equivalents fell 66.96% year-over-year to $225737.5; the TTM figure through Jun 2025 stood at $225737.5 (down 66.96% YoY), while the FY2024 annual figure was $2.2 million, up 186.98% from the prior year.
• Cash & Equivalents was $225737.5 for Q2 2025 at Medirom Healthcare Technologies, down from $2.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $13.2 million in Q2 2021 to a low of $225737.5 in Q2 2025.
• Historically, Cash & Equivalents has averaged $3.8 million across 5 years, with a median of $2.7 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Cash & Equivalents surged 175.4% in 2021, then slumped 84.54% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $13.2 million in 2021, then slumped by 80.05% to $2.6 million in 2022, then jumped by 56.14% to $4.1 million in 2023, then tumbled by 47.1% to $2.2 million in 2024, then sank by 89.58% to $225737.5 in 2025.
• The last three Cash & Equivalents figures came in at $225737.5 (Q2 2025), $2.2 million (Q4 2024), and $683162.4 (Q2 2024), per Business Quant data.